|
Orthologous residues
|
|
MUC1 (human): S1227‑p, MUC1 iso2 (human): S236‑p, MUC1 iso6 (human): S202‑p, MUC1 (mouse): S602‑p, MUC1 (rat): S46‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, peptide sequencing, phosphoamino acid analysis
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), HeLa (cervical)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
CTNNB1 (human)
|
|
Disrupts
|
|
|
electrophoretic visualization, co-immunoprecipitation
|
|